Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY: ABT )

110.93 USD -0.37 (-0.33%)
Streaming Delayed Price Updated: 9:50 AM EST, Jan 19, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Abbott Laboratories

< Previous 1 2 3 4 5 6 7 8 9
...
74 75 Next >
Pomerantz Law Firm Announces the Filing of a Class Action against Co-Diagnostics, Inc. and Certain Officers - CODX
Pomerantz LLP announces that a class action lawsuit has been filed against Co-Diagnostics, Inc. ("Co-Diagnostics" or the "Company")(NASDAQ: CODX) and certain of its officers. The class action, filed in... 
From PR Newswire
Why Biomarkers for Cancer Drug Development are Becoming Increasingly Imperative
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Why Biomarkers for Cancer Drug Development are Becoming Increasingly Imperative
Financialnewsmedia.com News Commentary 
From PR Newswire
K-12 Education Sector Turns to Absolute for Successful Distance Learning Programs Rooted in Endpoint Resilience
As school districts across the United States plan for the upcoming 2020 – 2021 school year, Absolute® (TSX:ABT), the leader in Endpoint Resilience™, today highlighted educational institutions – Anaheim... 
From Business Wire News Releases
Abbott and Tandem Diabetes Care Advance Development of Integrated Technologies for Future Automated Insulin Delivery Systems
- Companies partner to integrate Abbott's FreeStyle Libre continuous glucose monitoring technology with Tandem's insulin delivery products to provide options to simplify and tailor diabetes management 
From PR Newswire
New Research Finds Abbott's Optical Coherence Tomography Imaging Changed Treatment Decisions in 88% of Artery Blockages
-- Using optical coherence tomography (OCT)-guided percutaneous coronary intervention (PCI), physicians were able to select the right size stents and place them with greater precision 
From PR Newswire
New Late-Breaking Data Highlight Impact of Abbott's Minimally Invasive Structural Heart Therapies
- New data reinforce Abbott's leadership in minimally invasive treatment options for mitral and tricuspid repair and replacement therapies 
From PR Newswire
New Research from Absolute Underscores Vulnerability of Enterprise Devices and Critical Endpoint Controls, Reveals Opportunities to Optimize Security Investments
Absolute® (ABT.TO), the leader in Endpoint Resilience™, today announced it has published new research underscoring the massive amount of complexity plaguing today’s enterprise endpoint environments.... 
From Business Wire News Releases
Abbott Hosts Conference Call for Second-Quarter Earnings
Abbott (NYSE: ABT) will announce its second-quarter 2020 financial results on Thursday, July 16, 2020, before the market opens. 
From PR Newswire
Absolute Expands Sensitive Data and Device Protections for Remote Endpoints with Enhancements to Undeletable Defense Platform
Absolute® (ABT.TO), the leader in Endpoint Resilience™, today announced new platform capabilities enabling customers to strengthen sensitive data and endpoint device protections in remote or hybrid... 
From Business Wire News Releases
New Data Show Use of Abbott's FreeStyle® Libre System Reduces All-Cause, Diabetic Ketoacidosis-Related Hospitalization Rates and Acute Diabetes Events
Today, Abbott (NYSE: ABT) announced results from multiple new real-world studies1,2,3,4 that demonstrate how use of the FreeStyle Libre system, the world-leading5 continuous glucose monitoring (CGM)... 
From PR Newswire
Abbott's FreeStyle® Libre 2 iCGM Cleared in U.S. for Adults and Children with Diabetes, Achieving Highest Level of Accuracy and Performance Standards
- FreeStyle Libre 2 is the only integrated continuous glucose monitoring (iCGM) system available that continuously transmits glucose data every minute with customizable, optional real-time alarms to... 
From PR Newswire
New Late-Breaking Data Show Use of Abbott's FreeStyle® Libre System Significantly Reduces HbA1C Levels in People with Type 2 Diabetes Using Insulin or Not
- Real-world data(1) presented at the American Diabetes Association 80th Scientific Sessions suggest people with type 2 diabetes can achieve similar outcomes to adding insulin therapy for both... 
From PR Newswire
Abbott Declares 386th Consecutive Quarterly Dividend
The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 36 cents per share. 
From PR Newswire
Life-Saving Features Help Propel Wearable Technology to New Heights
FinancialBuzz.com News Commentary 
From PR Newswire
Anaheim Union High School District Protects Sizable Technology Investment with Absolute Endpoint Resilience
Absolute® (TSX: ABT), the leader in Endpoint Resilience™, announced today that Anaheim Union High School District, one of the largest school districts in California, selected the Absolute Control®... 
From Business Wire News Releases
Surmodics Receives CE Mark for its SurVeil™ Drug Coated Balloon
Surmodics announced it has received CE Mark Certification in the European Union for its SurVeil™ drug-coated balloon. 
From Business Wire News Releases
Wearable Devices Present an Economic Choice for Remote Patient Monitoring
FinancialBuzz.com News Commentary 
From PR Newswire
Pennsylvania Cyber Charter School Selects Absolute to Protect Mission-Critical Apps With Unbreakable Endpoint Resilience
Absolute® (TSX: ABT), the leader in Endpoint Resilience™, announced today that Pennsylvania Cyber Charter School, one of the largest, most experienced and successful online K-12 public schools in the... 
From Business Wire News Releases
Second Wave Concerns Create Urgent Need For Fast, Accurate Tests and Plausible Vaccines
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Second Wave Concerns Create Urgent Need For Fast, Accurate Tests and Plausible Vaccines
FN Media Group Presents Microsmallcap.com Market Commentary 
From PR Newswire
Abbott Releases Interim Clinical Study Data on ID NOW COVID-19 Rapid Test Showing Strong Agreement to Lab-Based Molecular PCR Tests
- Urgent care clinic study shows ID NOW test performance of ≥94.7% positive agreement (sensitivity) and ≥98.6% negative agreement (specificity) compared to lab-based PCR reference tests 
From PR Newswire
Absolute Honored as a Finalist in Two Categories for BC Tech Association’s 2020 Technology Impact Awards
Absolute® (ABT.TO), the leader in Endpoint Resilience™, announced that it has been selected as a finalist for two BC Tech Association 2020 Technology Impact Awards (TIAs), one for Company of the Year –... 
From Business Wire News Releases
Abbott Announces Contract to Supply Millions of IgG Lab-Based Antibody Tests to the UK Government
- Abbott's antibody test to be deployed as part of the UK Secretary of State for Health's initiative for highly-reliable, large-scale antibody testing 
From PR Newswire
Duarte Unified School District Protects Students While Fostering Student Engagement With Absolute Web Usage
Absolute® (ABT.TO), the leader in Endpoint Resilience™, announced Duarte Unified School District selected Absolute’s Web Usage to enable them to stand up, monitor, manage and measure their distance... 
From Business Wire News Releases
Absolute Powers K-12 Distance Learning Programs with the Launch of Web Usage
Absolute® (ABT.TO), the leader in Endpoint Resilience™, today announced the general availability of Web Usage for K-12 educational institutions to help stand up, monitor, manage and measure distance... 
From Business Wire News Releases
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Abbott Laboratories (ABT) on Behalf of Investors
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Abbott Laboratories (ABT) on Behalf of Investors 
From Business Wire News Releases
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Abbott Laboratories and Encourages Investors with Losses of $100,000 to Contact the Firm
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Abbott Laboratories. 
From Business Wire News Releases
The Law Offices of Frank R. Cruz Announces Investigation on Behalf of Abbott Laboratories Investors (ABT)
The Law Offices of Frank R. Cruz announces an investigation on behalf of Abbott Laboratories (“Abbott” or the “Company”) (NYSE: ABT) investors concerning the Company and its officers’ possible... 
From Business Wire News Releases
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Abbott Laboratories (ABT) on Behalf of Investors
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Abbott Laboratories (ABT) on Behalf of Investors 
From Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
74 75 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.